Yiming Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yiming Zhang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ying Weng
University of Nottingham Ningbo China
8 shared publications - Boding Wang
Department of Neurosurgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, 315000, China
3 shared publications - Akram A. Hosseini
Department of Academic Neurology, Queen’s Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
2 shared publications - Chengtai Li
University of Nottingham Ningbo China
2 shared publications - Tom Dening
University of Nottingham
2 shared publications Boding Wang
1 shared publication
Latest Publications
- Open Access
- 29 August 2025
- Published by Springer Nature in Artificial Intelligence Review
- Vol. 58 (11) , 1-58
Applications of machine learning for computer-aided diagnosis of Parkinson’s disease: progress and benchmark case study
Machine learning (ML) has emerged as a vital tool for the diagnosis of Parkinson’s Disease (PD). This study presents a comprehensive review on the applications of ML for computer-aided diagnosis (CAD) of PD. We conducted a comprehensive review by searching articles published from 2010 till 2024. The risk of bias is assessed using the PROBAST checklist. Case studies are also provided. This review includes 117 articles with six categories: neuroimaging data (20.5%); voice data (40.2%); handwriting data (12.0%); gait data (14.5%); EEG data (8.5%); and other data (4.3%). According to the PROBAST checklist, only 28 articles (23.9%) have a low risk of bias. A benchmark case study is conducted for five different data modalities. We also discuss current limitations and future directions of applying ML to the diagnosis of PD. This review reduces the gap between Artificial Intelligence (AI) and PD medical professionals and provides helpful information for future research.
- 29 August 2025
- Published by Springer Nature in Artificial Intelligence Review
- Vol. 58 (11) , 1-58
Open AccessApplications of machine learning for computer-aided diagnosis of Parkinson’s disease: progress and benchmark case study
Machine learning (ML) has emerged as a vital tool for the diagnosis of Parkinson’s Disease (PD). This study presents a comprehensive review on the applications of ML for computer-aided diagnosis (CAD) of PD. We conducted a comprehensive review by searching articles published from 2010 till 2024. The risk of bias is assessed using the PROBAST checklist. Case studies are also provided. This review includes 117 articles with six categories: neuroimaging data (20.5%); voice data (40.2%); handwriting data (12.0%); gait data (14.5%); EEG data (8.5%); and other data (4.3%). According to the PROBAST checklist, only 28 articles (23.9%) have a low risk of bias. A benchmark case study is conducted for five different data modalities. We also discuss current limitations and future directions of applying ML to the diagnosis of PD. This review reduces the gap between Artificial Intelligence (AI) and PD medical professionals and provides helpful information for future research.
- 12 May 2025
- Published by Springer Nature
- p. 197-210
A Computer Vision System for Automatic Edge Detection of Magnetic Grain Profile
- 12 May 2025
- Published by Springer Nature
- p. 197-210
A Computer Vision System for Automatic Edge Detection of Magnetic Grain Profile
- Open Access
- 26 October 2023
- Published by Elsevier in Neural Networks
- Vol. 169, 442-452
A comparative study of GNN and MLP based machine learning for the diagnosis of Alzheimer’s Disease involving data synthesis
- 26 October 2023
- Published by Elsevier in Neural Networks
- Vol. 169, 442-452
Open AccessA comparative study of GNN and MLP based machine learning for the diagnosis of Alzheimer’s Disease involving data synthesis
- Open Access
- 20 March 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (6) , 3923
A Survey of Secure Time Synchronization
Today, the use of wireless sensor networks has grown rapidly; however, wireless sensor networks are prone to receiving cyber-physical attacks. Time synchronization is a fundamental requirement for protocols in wired and wireless sensor network applications; hence, secure time synchronization is also crucial. This paper presents an introduction to time synchronization, including the concepts, challenges, and requirements of time synchronization protocols. The scope of the paper includes both software- and hardware-based protocols. Then, different time synchronization methods are analyzed. Moreover, research progress in secure time synchronization is reviewed. The survey also discusses the weaknesses of current secure time synchronization protocols and provides suggestions for future research directions. This survey aims to highlight research progress and trends in time synchronization and secure time synchronization.
- 20 March 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (6) , 3923
Open AccessA Survey of Secure Time Synchronization
Today, the use of wireless sensor networks has grown rapidly; however, wireless sensor networks are prone to receiving cyber-physical attacks. Time synchronization is a fundamental requirement for protocols in wired and wireless sensor network applications; hence, secure time synchronization is also crucial. This paper presents an introduction to time synchronization, including the concepts, challenges, and requirements of time synchronization protocols. The scope of the paper includes both software- and hardware-based protocols. Then, different time synchronization methods are analyzed. Moreover, research progress in secure time synchronization is reviewed. The survey also discusses the weaknesses of current secure time synchronization protocols and provides suggestions for future research directions. This survey aims to highlight research progress and trends in time synchronization and secure time synchronization.
- Open Access
- 1 February 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (3) , 537
A Systematic Review of Application Progress on Machine Learning-Based Natural Language Processing in Breast Cancer over the Past 5 Years
Artificial intelligence (AI) has been steadily developing in the medical field in the past few years, and AI-based applications have advanced cancer diagnosis. Breast cancer has a massive amount of data in oncology. There has been a high level of research enthusiasm to apply AI techniques to assist in breast cancer diagnosis and improve doctors’ efficiency. However, the wise utilization of tedious breast cancer-related medical care is still challenging. Over the past few years, AI-based NLP applications have been increasingly proposed in breast cancer. In this systematic review, we conduct the review using preferred reporting items for systematic reviews and meta-analyses (PRISMA) and investigate the recent five years of literature in natural language processing (NLP)-based AI applications. This systematic review aims to uncover the recent trends in this area, close the research gap, and help doctors better understand the NLP application pipeline. We first conduct an initial literature search of 202 publications from Scopus, Web of Science, PubMed, Google Scholar, and the Association for Computational Linguistics (ACL) Anthology. Then, we screen the literature based on inclusion and exclusion criteria. Next, we categorize and analyze the advantages and disadvantages of the different machine learning models. We also discuss the current challenges, such as the lack of a public dataset. Furthermore, we suggest some promising future directions, including semi-supervised learning, active learning, and transfer learning.
- 1 February 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (3) , 537
Open AccessA Systematic Review of Application Progress on Machine Learning-Based Natural Language Processing in Breast Cancer over the Past 5 Years
Artificial intelligence (AI) has been steadily developing in the medical field in the past few years, and AI-based applications have advanced cancer diagnosis. Breast cancer has a massive amount of data in oncology. There has been a high level of research enthusiasm to apply AI techniques to assist in breast cancer diagnosis and improve doctors’ efficiency. However, the wise utilization of tedious breast cancer-related medical care is still challenging. Over the past few years, AI-based NLP applications have been increasingly proposed in breast cancer. In this systematic review, we conduct the review using preferred reporting items for systematic reviews and meta-analyses (PRISMA) and investigate the recent five years of literature in natural language processing (NLP)-based AI applications. This systematic review aims to uncover the recent trends in this area, close the research gap, and help doctors better understand the NLP application pipeline. We first conduct an initial literature search of 202 publications from Scopus, Web of Science, PubMed, Google Scholar, and the Association for Computational Linguistics (ACL) Anthology. Then, we screen the literature based on inclusion and exclusion criteria. Next, we categorize and analyze the advantages and disadvantages of the different machine learning models. We also discuss the current challenges, such as the lack of a public dataset. Furthermore, we suggest some promising future directions, including semi-supervised learning, active learning, and transfer learning.
- Open Access
- 12 January 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (2) , 286
Natural Language Processing Applications for Computer-Aided Diagnosis in Oncology
In the era of big data, text-based medical data, such as electronic health records (EHR) and electronic medical records (EMR), are growing rapidly. EHR and EMR are collected from patients to record their basic information, lab tests, vital signs, clinical notes, and reports. EHR and EMR contain the helpful information to assist oncologists in computer-aided diagnosis and decision making. However, it is time consuming for doctors to extract the valuable information they need and analyze the information from the EHR and EMR data. Recently, more and more research works have applied natural language processing (NLP) techniques, i.e., rule-based, machine learning-based, and deep learning-based techniques, on the EHR and EMR data for computer-aided diagnosis in oncology. The objective of this review is to narratively review the recent progress in the area of NLP applications for computer-aided diagnosis in oncology. Moreover, we intend to reduce the research gap between artificial intelligence (AI) experts and clinical specialists to design better NLP applications. We originally identified 295 articles from the three electronic databases: PubMed, Google Scholar, and ACL Anthology; then, we removed the duplicated papers and manually screened the irrelevant papers based on the content of the abstract; finally, we included a total of 23 articles after the screening process of the literature review. Furthermore, we provided an in-depth analysis and categorized these studies into seven cancer types: breast cancer, lung cancer, liver cancer, prostate cancer, pancreatic cancer, colorectal cancer, and brain tumors. Additionally, we identified the current limitations of NLP applications on supporting the clinical practices and we suggest some promising future research directions in this paper.
- 12 January 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (2) , 286
Open AccessNatural Language Processing Applications for Computer-Aided Diagnosis in Oncology
In the era of big data, text-based medical data, such as electronic health records (EHR) and electronic medical records (EMR), are growing rapidly. EHR and EMR are collected from patients to record their basic information, lab tests, vital signs, clinical notes, and reports. EHR and EMR contain the helpful information to assist oncologists in computer-aided diagnosis and decision making. However, it is time consuming for doctors to extract the valuable information they need and analyze the information from the EHR and EMR data. Recently, more and more research works have applied natural language processing (NLP) techniques, i.e., rule-based, machine learning-based, and deep learning-based techniques, on the EHR and EMR data for computer-aided diagnosis in oncology. The objective of this review is to narratively review the recent progress in the area of NLP applications for computer-aided diagnosis in oncology. Moreover, we intend to reduce the research gap between artificial intelligence (AI) experts and clinical specialists to design better NLP applications. We originally identified 295 articles from the three electronic databases: PubMed, Google Scholar, and ACL Anthology; then, we removed the duplicated papers and manually screened the irrelevant papers based on the content of the abstract; finally, we included a total of 23 articles after the screening process of the literature review. Furthermore, we provided an in-depth analysis and categorized these studies into seven cancer types: breast cancer, lung cancer, liver cancer, prostate cancer, pancreatic cancer, colorectal cancer, and brain tumors. Additionally, we identified the current limitations of NLP applications on supporting the clinical practices and we suggest some promising future research directions in this paper.
- Top Cited PapersOpen Access
- 19 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 237
Applications of Explainable Artificial Intelligence in Diagnosis and Surgery
In recent years, artificial intelligence (AI) has shown great promise in medicine. However, explainability issues make AI applications in clinical usages difficult. Some research has been conducted into explainable artificial intelligence (XAI) to overcome the limitation of the black-box nature of AI methods. Compared with AI techniques such as deep learning, XAI can provide both decision-making and explanations of the model. In this review, we conducted a survey of the recent trends in medical diagnosis and surgical applications using XAI. We have searched articles published between 2019 and 2021 from PubMed, IEEE Xplore, Association for Computing Machinery, and Google Scholar. We included articles which met the selection criteria in the review and then extracted and analyzed relevant information from the studies. Additionally, we provide an experimental showcase on breast cancer diagnosis, and illustrate how XAI can be applied in medical XAI applications. Finally, we summarize the XAI methods utilized in the medical XAI applications, the challenges that the researchers have met, and discuss the future research directions. The survey result indicates that medical XAI is a promising research direction, and this study aims to serve as a reference to medical experts and AI scientists when designing medical XAI applications.
- 19 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 237
Top Cited PapersOpen AccessApplications of Explainable Artificial Intelligence in Diagnosis and Surgery
In recent years, artificial intelligence (AI) has shown great promise in medicine. However, explainability issues make AI applications in clinical usages difficult. Some research has been conducted into explainable artificial intelligence (XAI) to overcome the limitation of the black-box nature of AI methods. Compared with AI techniques such as deep learning, XAI can provide both decision-making and explanations of the model. In this review, we conducted a survey of the recent trends in medical diagnosis and surgical applications using XAI. We have searched articles published between 2019 and 2021 from PubMed, IEEE Xplore, Association for Computing Machinery, and Google Scholar. We included articles which met the selection criteria in the review and then extracted and analyzed relevant information from the studies. Additionally, we provide an experimental showcase on breast cancer diagnosis, and illustrate how XAI can be applied in medical XAI applications. Finally, we summarize the XAI methods utilized in the medical XAI applications, the challenges that the researchers have met, and discuss the future research directions. The survey result indicates that medical XAI is a promising research direction, and this study aims to serve as a reference to medical experts and AI scientists when designing medical XAI applications.
- 7 November 2013
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 6 (2) , 503-508
A GC/MS method for the simultaneous determination and quantification of chlorpromazine and diazepam in pork samples
A gas chromatography coupled with mass spectrometry (GC/MS) method for the simultaneous determination of chlorpromazine and diazepam in pork samples, which are two of the most often used antipsychotics, has been developed and validated. The samples were prepared and purified by solid-phase extraction (SPE), and then were analyzed by GC/MS. Chromatography was performed using an HP-5 MS 5% phenyl–95% methylpolysiloxane fused silica capillary column (30 m × 0.25 mm; film thickness 0.25 μm). The method had a linear calibration curve over the range 10–500 ng mL−1 (r > 0.99), recovery (>66.5% for chlorpromazine and >77.4% for diazepam), precision (%RSD < 11.5% for chlorpromazine and −1. This method can result in faster analysis, lower solvent consumption and less workload per sample while maintaining or even improving sensitivity.
- 7 November 2013
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 6 (2) , 503-508
A GC/MS method for the simultaneous determination and quantification of chlorpromazine and diazepam in pork samples
A gas chromatography coupled with mass spectrometry (GC/MS) method for the simultaneous determination of chlorpromazine and diazepam in pork samples, which are two of the most often used antipsychotics, has been developed and validated. The samples were prepared and purified by solid-phase extraction (SPE), and then were analyzed by GC/MS. Chromatography was performed using an HP-5 MS 5% phenyl–95% methylpolysiloxane fused silica capillary column (30 m × 0.25 mm; film thickness 0.25 μm). The method had a linear calibration curve over the range 10–500 ng mL−1 (r > 0.99), recovery (>66.5% for chlorpromazine and >77.4% for diazepam), precision (%RSD < 11.5% for chlorpromazine and −1. This method can result in faster analysis, lower solvent consumption and less workload per sample while maintaining or even improving sensitivity.